Long Noncoding RNA WDFY3-AS2 Represses the Progression of Esophageal Cancer through miR-18a/PTEN Axis

Qingling Kong1, Guangcai Li2, Gang Yin3

  • 1Hospital Infection Control Office, Rizhao People's Hospital, Rizhao 276800, China.

Journal of Oncology
|July 1, 2021
PubMed
Abstract

Insights

Long non-coding RNA WDFY3-AS2 is underexpressed in esophageal cancer (EC), inhibiting tumor progression. WDFY3-AS2 acts as a ceRNA by sponging miR-18a to regulate PTEN, suggesting a novel therapeutic target for EC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long non-coding RNAs (lncRNAs) are crucial in human cancer development, necessitating research into their roles in esophageal cancer (EC).
  • The specific function and regulatory mechanisms of lncRNA WDFY3-AS2 in EC remain largely unknown.
  • This study investigates the functional role and regulatory mechanism of WDFY3-AS2 in EC progression.

Purpose of the Study:

  • To elucidate the functional role of lncRNA WDFY3-AS2 in esophageal cancer.
  • To investigate the regulatory mechanism of WDFY3-AS2 in EC.
  • To explore the potential of WDFY3-AS2 as a therapeutic target for EC.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) to assess WDFY3-AS2 and miR-18a expression levels in EC tissues and cells.
  • Luciferase reporter and RNA immunoprecipitation (RIP) assays to determine the interaction between WDFY3-AS2, miR-18a, and PTEN.
  • Cell Counting Kit-8 (CCK-8) and Transwell assays to evaluate cell viability, migration, and invasion.

Main Results:

  • WDFY3-AS2 was found to be underexpressed in EC specimens and cells, correlating with poor patient prognosis.
  • Re-expression of WDFY3-AS2 significantly inhibited EC cell proliferation, migration, and invasion.
  • WDFY3-AS2 negatively correlated with miR-18a and positively with PTEN, with WDFY3-AS2 overexpression rescuing PTEN levels suppressed by miR-18a mimic.

Conclusions:

  • WDFY3-AS2 functions as a competing endogenous RNA (ceRNA) by sponging miR-18a, thereby modulating PTEN expression in EC.
  • The WDFY3-AS2/miR-18a/PTEN pathway is implicated in the progression of esophageal cancer.
  • WDFY3-AS2 represents a potential therapeutic target for esophageal cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K